Toshie Mashiba

Amino acid imbalance in patients with chronic liver diseases

Kojiro Michitaka, Atsushi Hiraoka, Misaki Kume et al. · Hepatology Research · 2010 · 54 citations

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki et al. · PLoS ONE · 2018 · 54 citations · Full text

Wilms’ tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis

Toshiki Sera, Yoichi Hiasa, Toshie Mashiba et al. · European Journal of Cancer · 2008 · 51 citations

Hepatology, Medicine, Pathology +8

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

Hironori Ochi, Masayuki Kurosaki, Kouji Joko et al. · Hepatology Research · 2022 · 45 citations · Full text

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

Hironori Ochi, Atsushi Hiraoka, Masashi Hirooka et al. · Journal of Gastroenterology · 2020 · 41 citations · Full text